Presentation is loading. Please wait.

Presentation is loading. Please wait.

Boston Children’s Hospital, Harvard Medical School

Similar presentations


Presentation on theme: "Boston Children’s Hospital, Harvard Medical School"— Presentation transcript:

1 Boston Children’s Hospital, Harvard Medical School
Impact of Pacing on Systemic Ventricular Function in L-Transposition of the Great Arteries Sophie C. Hofferberth, MBBS, Mark E. Alexander, MD, Douglas Y. Mah, MD, Victor Bautista-Hernandez, MD, Pedro J. del Nido, MD, Francis Fynn-Thompson, MD Introduction remarks Boston Children’s Hospital, Harvard Medical School AATS 2015

2 Disclosures None of the authors in this study have any commercial relationships to disclose

3 Congenitally Corrected Transposition of the Great Arteries (ccTGA)
ccTGA is a complex cardiac anomaly defined by atrioventricular (AV) and ventriculoarterial discordance Native ccTGA physiology leaves morphological RV to support systemic circulation Late onset RV dysfunction Systemic AV regurgitation Surgical management has evolved to anatomical repair Excellent perioperative/intermediate outcomes late systemic ventricular dysfunction remains significant problem1,2 1. Hiramatsu et al . EJCTS 2012;42(6): ; 2. Bautista-Hernandez et al. JTCVS. 2014;148(1):254-8.

4 Pacing and Systemic Ventricular Dysfunction
ccTGA has high incidence of spontaneous and procedure-related heart block Pacemaker insertion associated with late-onset systemic ventricular dysfunction post anatomical repair1,2 Univentricular (single site) pacing shown to be significant risk factor for ventricular dysfunction Biventricular pacing (BiVP) appears to preserve systemic ventricular function -It is well recognized that l-tga pts have a high incidence of spontaneous and procedure-related hb. -recent reports from our institution demonstrate that pacemaker insertion is assoc with late onset syst vent dysfxn in ltga pts post anatomical repair, more specifically these earlier reports showed univentricular (single site ) pacing is a major RF for ventricular dysfxn, while conversely pts who received biventricular pacing (CRT) appeared have have p Bautista-Hernandez et al. Ann Thor Surg. 2006;82(6): Bautista-Hernandez et al. JTCVS. 2014;148(1):254-8.

5 Methods Aim Compare the impact of univentricular versus biventricular pacing on systemic ventricular function in all pts with ccTGA Methods Retrospective analysis of all pts with diagnosis of ccTGA who received pacemakers between 1993 and 2014 Study endpoints Timing and indication for pacemaker insertion Location of ventricular lead(s) Qualitative ventricular function Clinical outcomes

6 Baseline Patient Characteristics
Variable Number (%) or Median (range) Total number of pts 53 Male/Female 31/22 Median age at initial pacer insertion 1.8 years (6 days - 42 years) Median weight, Kg 10.8 (3.5 to 69.0) Segmental anatomy S,L,L 49 (92) I,D,D 4 (8) Associated CV anomalies VSD 42 (79) Pulmonary stenosis 25 (47) Pulmonary atresia 10 (19) Ebstein-like anomaly 9 (17) Single coronary artery 3 (6) This study included a 53 pts and the demographic and co-morbidity profiles of this cohort is representative of the contemporary surgical population of L-TGA patients.

7 No further pacing intervention
Pacing Details Primary univentricular pacing 42 pts Epicardial lead location - Anatomic LV, n = 28 - Anatomic RV, n = 11 - Ambiguous data, n = 3 Primary biventricular pacing 11 pts No further pacing intervention N = 25 Upgraded to BiV pacing N = 17

8 Timing of Initial Pacemaker Insertion
Spontaneous heart block, n = 8 Time of surgical intervention preparing for anatomical repair, n = 9 PA Banding, n = 8 BT shunt, n = 1 Time of anatomical repair, n = 8 Post anatomical repair, n = 28

9 Outcomes: Primary Univentricular Pacing
Initial univentricular pacer N = 42 Systemic ventricular dysfunction N = 22 No ventricular dysfunction N = 20 Upgrade to BiVP N = 14 No further pacing intervention N = 8 Upgrade to BiVP N = 3 No further pacing intervention N = 17 Persistent systemic ventricular dysfunction N = 7 Improved systemic ventricular function N = 7 2 late deaths (heart failure) Important additional comments: 22 pts with significant systemic vent dysfunction8 pts had no further pacing intervention, of these 2 late deaths, remaining 6 pts 1 pt listed for transplantation, BiV pacing, further anatomical repair 14 upgraded to CRT, explain outcomes of 7 with persistent systemic vent dysfunction, 7 pts demonstrated improved ventricular function No major CV events amongst this group, improved QOL/exercise tolerance 20 pts with no significant ventricular dysfunction, of these 17 pts had no further pacing intervention, no significant late CV events in this group. 3 pts in this gp were upgraded to CRT at the time of anatomical repair. This was decision was made at the discretion of the operating surgeon and took place during the past few yrs as our experience shifted 1 in-hospital death (heart failure) 1 late death (heart failure) 1 transplant

10 Lead placement & Systemic Ventricular Function
Initial univentricular pacing, N = 42 Systemic ventricular dysfunction N = 22 Lead placement on anatomic LV N = 13 Lead placement on anatomic RV N = 9 Sub-systemic lead N = 6 Sub-pulmonary lead N = 7 Sub-systemic lead N = 4 Sub-pulmonary lead N = 5 No difference in risk of systemic ventricular dysfunction based on initial lead location whether analyzed by ventricular morphology or physiologic function

11 Outcomes: Primary Biventricular Pacing
Median age = 1.2 yrs (range, 5 mths to 16 yrs) Median weight = 10.9 kg (range, 5 to 59 kg) 6 male, 5 female No perioperative complications No major CV complications (i.e. no mortality/heart failure/transplantation) None of the pts treated with primary biventricular pacing developed systemic ventricular dysfunction at latest follow up

12 Univentricular versus Biventricular Pacing
We next performed a life-table analysis which demonstrated a striking difference in late outcomes between univentricular vs BiV paced pts. Freedom from systemic ventricular dysfunction was 100% at 10 years for pts who received primary BiV pacing compared to just over 40% for those pts who underwent primary univentricular pacing.

13 Late Follow-up Primary biventricular pacing (n = 11)
Overall median follow up = 3.7 yrs (range, 4 days yrs) Primary biventricular pacing (n = 11) Median follow up = 3 yrs (range, 4 d - 9 yrs) Primary univentricular pacing (n = 42) 25 pts: no further pacing intervention Median F/U = 4.2 yrs (range, 4 d - 16 yrs) 17 pts: upgraded to BiVP Median time from initial univentricular pacer insertion to BiVP upgrade = 3 yrs (range, 3 mths - 22 yrs) Median time from upgrade to demonstrated improvement in ventricular function (6 pts) = 8 wks (range, 2 – 20 wks)

14 Limitations Retrospective, single-center analysis
Extended follow-up in univentricular pacing cohort may display natural history of systemic RV in addition to consequences of single site pacing Variable location of biventricular leads driven by uncertainty over exact site of latest electrical activation and limited surgical access Some pts upgraded to biventricular pacing at time of further anatomic correction Subjective classification of ventricular function in paced ventricles

15 Conclusions ccTGA pts have a high frequency of both AV block and late ventricular dysfunction While ventricular pacing is clearly required, single site ventricular pacing appears to contribute to earlier ventricular dysfunction Neither morphologic nor physiologic consideration of single lead placement predicts late ventricular dysfunction Upgrade to BiVP offers a reasonable (50%) chance of short term normalization of ventricular function Primary BiVP prevents (or at least delays) development of ventricular dysfunction Based on the results of studies we believe that BiV pacing should be the primary mode of pacing in all pts with ccTGA who develop heart block in order to mitigate the risks of developing systemic ventricular dysfunction.

16 Thank you


Download ppt "Boston Children’s Hospital, Harvard Medical School"

Similar presentations


Ads by Google